Thus, further longitudinal studies are needed to elucidate the causal or sequential relation among olfactory dysfunction, Aβ and tau pathology, neurodegeneration, and cognitive decline in the trajectory of AD. This evidence concerns the gene MAPT and Alzheimer disease.